6 Results for "

PRB2

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "PRB2" in MCE Product Catalog:

Cat. No.: HY-RS11052
Research Areas:  

Others

PRB2 Human Pre-designed siRNA Set A contains three designed siRNAs for PRB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P81302
Synonyms: RB2; RBL2; Retinoblastoma-like protein 2; 130 kDa retinoblastoma-associated protein; Retinoblastoma-related protein 2; PRB2; p130; RBR-2

Host:  

Rabbit

Application:  

WB, IHC-F, IHC-P, ICC/IF

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P81302A
Synonyms: RB2; RBL2; Retinoblastoma-like protein 2; 130 kDa retinoblastoma-associated protein; Retinoblastoma-related protein 2; PRB2; p130; RBR-2

Host:  

Rabbit

Application:  

WB, IP, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P81302AA
Synonyms: RB2; RBL2; Retinoblastoma-like protein 2; 130 kDa retinoblastoma-associated protein; Retinoblastoma-related protein 2; PRB2; p130; RBR-2

Host:  

Rabbit

Application:  

WB, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-RS21415
Research Areas:  

Others

Rbl2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rbl2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-186132
CAS No.: 3030276-48-0
Target:  

PROTACs CDK

Research Areas:  

Cancer

PROTAC CDK2-pRb degrader-1 is an orally active PROTAC-class degrader of CDK2. PROTAC CDK2-pRb degrader-1 effectively inhibits the phosphorylation of retinoblastoma protein (Rb) at serine residues 807/811 by inducing ubiquitination and proteasomal degradation of CDK2. PROTAC CDK2-pRb degrader-1 exhibits significant activity against human cells (with EC50 values of 12 nM and 125 nM, respectively). In xenograft models, PROTAC CDK2-pRb degrader-1 effectively inhibits tumor growth and induces tumor stasis, making it suitable for research related to CCNE1-amplified cancers (such as ovarian cancer, gastric cancer, and breast cancer) .
loading...
    loading...